Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Pre-tax income — Domestic (U.S.) by Year
Pre-tax income — Domestic (U.S.) ($M) ($M)
Vertex Pharmaceuticals Pre-tax income — Domestic (U.S.): $2,821M in FY2025, down 306.0% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Income Taxes — Domestic vs. Foreign Pre-Tax Income).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pre-tax income — Domestic (U.S.) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,821 | -306.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | -1,370 | -144.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 3,089 | -5.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 3,257 | +60.4% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 2,031 | -29.6% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 2,885 | +128.4% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 1,263 | +55.6% | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 812 | +145.9% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 330 | -323.3% | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | -148 | -45.7% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | -272 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Pre-tax income — Domestic (U.S.) ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/pretax-dom
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.